Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24314942 | 0.88 | KDM4E (0.34) | MEN1ALDH1A1KMT2AKDM4ETP53 | |
| SCHEMBL25840933 | 0.80 | BACE1 (0.33) | — | |
| SCHEMBL24353198 | 0.79 | MEN1 (0.49) | MEN1ALDH1A1KMT2AKDM4ETP53 | |
| SCHEMBL27252873 | 0.79 | MEN1 (0.49) | MEN1ALDH1A1KMT2AKDM4ETP53 | |
| SCHEMBL24353189 | 0.79 | MEN1 (0.49) | MEN1ALDH1A1KMT2AKDM4ETP53 | |
| SCHEMBL24353262 | 0.79 | MEN1 (0.51) | MEN1ALDH1A1KMT2AKDM4ETP53 | |
| SCHEMBL31643022 | 0.78 | MEN1 (0.47) | MEN1ALDH1A1KMT2AKDM4ETP53 | |
| SCHEMBL26592019 | 0.78 | MEN1 (0.47) | MEN1ALDH1A1KMT2AKDM4ETP53 | |
| SCHEMBL31642593 | 0.78 | MEN1 (0.50) | MEN1ALDH1A1KMT2AKDM4ETP53 | |
| SCHEMBL24353264 | 0.78 | MEN1 (0.50) | MEN1ALDH1A1KMT2AKDM4ETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4159724-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | Duk San Neolux Co., Ltd. (KR) | 2023-04-05 | — | — | EP | disclosed |
| US-20170119673-A1 | APPARATUS AND METHOD FOR CRYOGRANULATING A PHARMACEUTICAL COMPOSITION | MANNKIND CORPORATION (US) | 2017-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119673-A1 | APPARATUS AND METHOD FOR CRYOGRANULATING A PHARMACEUTICAL COMPOSITION | EXOSC9, EXOSC5, EXOSC4 | MEN1 3771/4885ALDH1A1 2301/4885KMT2A 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.